Global QYResearch
GlobalQYResearch (http://globalqyresearch.com/) is the one spot destination for all your research needs.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Graphite Digital
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences through meaningful digital experiences. Our teams of specialists help clients…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Healthcare Research Worldwide
We are market research experts in the healthcare, pharmaceutical, device and diagnostics space, and have a wealth of experience in a wide range of therapy areas. Our scientifically grounded approaches…
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Origins – The Patient Focused Specialists
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Visions4Health
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
Skylines and Oncology Headlines in Chicago for ASCO 2023
Press Releases | June 19, 2023 | Medscape Education
ASCO 2023 was a huge success for Medscape Oncology with connections made with members and conference attendees during the event at the Medscape Oncology booth on the exhibit floor and...
Boost engagement during virtual events and meetings
Videos and Podcasts | June 15, 2023 | Impetus Digital
Tip #7 - How do you increase engagement during virtual events? Make it fun! ️ See all Top 10 tips: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/ To learn more, visit us at http://impetusdigital.com/Book a demo today http://www.meetwithimpetus.com/
Medscape Oncology and American Society of Clinical Oncology Collaborate to Offer Cancer-Specific Training to Multidisciplinary Members of the Oncology Care Team
Press Releases | June 15, 2023 | Medscape Education
This week Medscape Oncology announced an exciting collaboration with ASCO® which you read on the Cision PR news wire here or below:The American Society of Clinical Oncology (ASCO®), a leader at...
Elevating Nephrology Outcomes at #ERA23
Press Releases | June 15, 2023 | Medscape Education
Medscape is headed back to Milano, Italy for the 2023 European Renal Association conference, #ERA23.This year, the team is elevating the outcomes of recent nephrology education programs to share the story...
From Multichannel to Omnichannel
White Papers and Resources | June 13, 2023 | Mednet
Take a look at the movement to omnichannel communication
How to Increase Engagement During Virtual Events
Videos and Podcasts | June 8, 2023 | Impetus Digital
Here's tip 8 of 10 on how to increase engagement during virtual events. Learn more tips at https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/ To find out more about how Impetus Digital can aid pharma and life...
Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
Press Releases | June 6, 2023 | Medscape Education
The Medscape Education team will be on site at the 2023 EHA conference in Frankfurt, Germany to share the outcomes of recent hematology education programs and to advance the discussion on...
Archetypes: Rethinking go-to-market expectations to drive commercial success
White Papers and Resources | June 6, 2023 | Avalere Health
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Navigating patients step by step on their clinical trial journey
Videos and Podcasts | June 5, 2023 | Innovative Trials
For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in...
Innovative Trials responds to national recommendations to tackle UK clinical trial decline
Press Releases | June 5, 2023 | Innovative Trials
Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.